𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease-modifying antirheumatic drugs, and anti–tumor necrosis factor therapy

✍ Scribed by Frederick Wolfe; Liron Caplan; Kaleb Michaud

Book ID
111698666
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
75 KB
Volume
54
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with tumor necrosis factor inh
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
✍ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt Rantapää-Dahlqvist; Jo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 3 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients

No evidence of association between anti–
No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
✍ Mark Lunt; Kath D. Watson; William G. Dixon; British Society for Rheumatology Bi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Objective To study the association between anti–tumor necrosis factor (anti-TNF) therapy and mortality in a national cohort of patients with rheumatoid arthritis. ## Methods We prospectively followed up 12,672 patients who were beginning anti-TNF therapy and 3,522 biologic-naive patients recei

Genome-wide association study of genetic
Genome-wide association study of genetic predictors of anti–tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci
✍ Darren Plant; John Bowes; Catherine Potter; Kimme L. Hyrich; Ann W. Morgan; Anth 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Objective Anti–tumor necrosis factor (anti-TNF) agents are successful therapies in rheumatoid arthritis (RA); however, inadequate response occurs in 30–40% of patients treated. Knowledge of the genetic factors that influence response may facilitate personalized therapy. The purpose of this study